Medicare Enrolled
Dr. Antonio Velasco, D.O.
Pulmonary Disease · Mullica Hill, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Velasco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Velasco?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Velasco
Dr. Antonio Velasco is a pulmonary disease specialist in Mullica Hill, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Velasco performed 1,724 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Velasco received a total of $7,277 from 43 pharmaceutical and/or device companies across 435 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Velasco is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 43% volume in NJ
$7,277 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,724
Medicare services
Top 43% in NJ for pulmonary disease
Not available
Unique patients (not deduplicated)
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
387 | $101 | $284 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
357 | $67 | $161 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
286 | $101 | $246 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
164 | $181 | $596 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
98 | $146 | $430 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
87 | $68 | $200 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
75 | $47 | $185 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
71 | $38 | $145 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
52 | $23 | $120 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
51 | $110 | $291 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $120 | $365 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
31 | $31 | $200 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
12 | $185 | $720 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
12 | $98 | $244 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,277
Total received (2018-2024)
Avg $1,040/year across 7 years
Top 19% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
435
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,031
2023
$1,194
2022
$1,062
2021
$1,289
2020
$506
2019
$665
2018
$529
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$613
GlaxoSmithKline, LLC.
$460
GENZYME CORPORATION
$198
Philips North America LLC
$100
SANOFI-AVENTIS U.S. LLC
$85
Boehringer Ingelheim Pharmaceuticals, Inc.
$85
PFIZER INC.
$71
Regeneron Healthcare Solutions, Inc.
$68
Genentech USA, Inc.
$54
Inspire Medical Systems, Inc.
$44
Electromed, Inc.
$39
Grifols USA, LLC
$35
Takeda Pharmaceuticals U.S.A., Inc.
$33
Amgen Inc.
$33
Insmed, Inc.
$31
Mylan Specialty L.P.
$18
Resmed Corp
$17
JAZZ PHARMACEUTICALS INC.
$17
Actelion Pharmaceuticals US, Inc.
$16
Janssen Biotech, Inc.
$14
Top 3 companies account for 62.6% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,132
AstraZeneca Pharmaceuticals LP
$1,758
Boehringer Ingelheim Pharmaceuticals, Inc.
$357
Regeneron Healthcare Solutions, Inc.
$336
GENZYME CORPORATION
$317
Mylan Specialty L.P.
$229
Genentech USA, Inc.
$223
Philips Electronics North America Corporation
$158
Insmed, Inc.
$158
PFIZER INC.
$121
Novartis Pharmaceuticals Corporation
$119
Amgen Inc.
$105
Philips North America LLC
$100
SANOFI-AVENTIS U.S. LLC
$98
Grifols USA, LLC
$89
Abbott Laboratories
$89
JAZZ PHARMACEUTICALS INC.
$76
Actelion Pharmaceuticals US, Inc.
$73
Harmony Biosciences LLC
$72
Takeda Pharmaceuticals U.S.A., Inc.
$51
Baxter Healthcare
$45
Inspire Medical Systems, Inc.
$44
Advanced Respiratory, Inc
$44
Merck Sharp & Dohme LLC
$41
Electromed, Inc.
$39
United Therapeutics Corporation
$39
Circassia Pharmaceuticals Inc
$37
Edwards Lifesciences Corporation
$34
Resmed Corp
$33
Mallinckrodt Hospital Products Inc.
$32
IDORSIA PHARMACEUTICALS US INC
$30
Axsome Therapeutics, Inc.
$29
Janssen Pharmaceuticals, Inc
$26
ADVANCED RESPIRATORY, INC
$17
Pulmonx Corporation
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Paratek Pharmaceuticals, Inc.
$15
Janssen Biotech, Inc.
$14
HARMONY BIOSCIENCES LLC
$13
Mallinckrodt Enterprises LLC
$13
Olympus America Inc.
$13
Teva Pharmaceuticals USA, Inc.
$13
La Jolla Pharmaceutical Company
$13
Top 3 companies account for 58.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · 120V · 60Hz · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · Adempas · AirDuo Digihaler · Arikayce · Astral · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · Ellipse ICD · Esbriet · FARXIGA · FASENRA · Fortify Assura · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · INSPIRE · Life 2000 Ventilation System · NO PRODUCT DISCUSSED · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENITRAM · PREVNAR 20 · Prolastin-C Liquid · QUVIVIQ · SMARTVEST · SPIRIVA RESPIMAT · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TREMFYA · TUDORZA PRESSAIR · The MetaNeb System · The Vest System Model 105 Home Care · UPTRAVI · Volara System · WAKIX · Wakix · XARELTO · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
245
County median income
$102,807
Nearest hospital to ZIP centroid (approximate)
NORTHBROOK BEHAVIORAL HEALTH HOSPITAL
9.9 mi
9.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Velasco is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Velasco experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Velasco performed 387 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Velasco receive payments from pharmaceutical companies?
Yes. Dr. Velasco received a total of $7,277 from 43 companies across 435 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Velasco's costs compare to other pulmonary diseases in Mullica Hill?
Dr. Velasco's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Velasco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Mullica Hill
Browse pulmonary diseases in Mullica Hill ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology